Cibus, Inc. (NASDAQ:CBUS) Short Interest Up 8.8% in December

Cibus, Inc. (NASDAQ:CBUS - Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 2,230,000 shares, a growth of 8.8% from the November 30th total of 2,050,000 shares. Currently, 11.9% of the company's stock are sold short. Based on an average daily trading volume, of 168,500 shares, the days-to-cover ratio is presently 13.2 days.

Cibus Trading Up 7.8 %

CBUS stock traded up $0.20 during mid-day trading on Tuesday, hitting $2.78. 307,747 shares of the company were exchanged, compared to its average volume of 141,768. The firm has a fifty day simple moving average of $4.03 and a 200 day simple moving average of $5.83. The company has a market capitalization of $73.55 million, a PE ratio of -0.12 and a beta of 1.86. Cibus has a twelve month low of $2.35 and a twelve month high of $23.18.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Canaccord Genuity Group restated a "buy" rating and set a $20.00 target price on shares of Cibus in a research note on Tuesday, October 22nd. HC Wainwright restated a "buy" rating and set a $25.00 price objective on shares of Cibus in a research note on Monday, November 11th. Finally, Alliance Global Partners dropped their price objective on Cibus from $25.00 to $23.50 and set a "buy" rating on the stock in a report on Tuesday, September 24th.

Hedge Funds Weigh In On Cibus

A number of hedge funds have recently bought and sold shares of the company. SG Americas Securities LLC acquired a new stake in Cibus during the third quarter valued at approximately $33,000. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Cibus during the 3rd quarter valued at approximately $44,000. Virtu Financial LLC acquired a new stake in shares of Cibus during the 3rd quarter valued at approximately $48,000. HighTower Advisors LLC lifted its stake in Cibus by 20.6% during the third quarter. HighTower Advisors LLC now owns 16,125 shares of the company's stock worth $52,000 after purchasing an additional 2,750 shares during the last quarter. Finally, Barclays PLC boosted its holdings in Cibus by 287.2% in the third quarter. Barclays PLC now owns 20,269 shares of the company's stock worth $66,000 after purchasing an additional 15,034 shares during the period. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.